Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
- PMID: 12547409
- DOI: 10.1016/s0168-8278(02)00360-4
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
Abstract
Background/aims: We conducted a retrospective cohort study to investigate factors to early and late phase recurrence of hepatocellular carcinoma (HCC).
Methods: The study population consisted of 249 patients including 157 with cirrhosis who underwent hepatectomy for HCC. The endpoint was time-to-recurrence. Using a Cox regression model, factors to early and late phase recurrences were investigated censoring recurrence-free patients at the 2-year time point and in patients without recurrence at 2 years.
Results: Actuarial probability of overall recurrence at 1, 3, and 5 years were 0.301, 0.623, and 0.790, respectively, with a median follow-up of 624 days. Early recurrence was observed in 123 out of 249 patients; while late recurrence was found in 61 out of 113 patients. Factors to early recurrence were as follows: non-anatomical resection, presence of microscopic vascular invasion, and serum alpha-fetoprotein level >or=32 ng/ml. Those contributing to late phase recurrence were higher grade of hepatitis activity, multiple tumors, and gross tumor classification.
Conclusions: Variables associated with metastatic recurrence were factors to early phase recurrence; whereas those related with elevated carcinogenesis contributed to late phase recurrence, thus providing an epidemiological evidence that different mechanisms, i.e. metastasis and de novo, are involved in intrahepatic recurrence after hepatectomy for HCC.
Comment in
-
Prognostic factors after resection of hepatocellular carcinoma: are there landmarks in the wild forest?J Hepatol. 2003 Feb;38(2):237-9. doi: 10.1016/s0168-8278(02)00407-5. J Hepatol. 2003. PMID: 12547414 Review. No abstract available.
Similar articles
-
Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.Ann Surg Oncol. 2011 Jul;18(7):1955-63. doi: 10.1245/s10434-010-1540-z. Epub 2011 Jan 15. Ann Surg Oncol. 2011. PMID: 21240562
-
Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection.HPB (Oxford). 2015 May;17(5):422-7. doi: 10.1111/hpb.12367. Epub 2014 Nov 24. HPB (Oxford). 2015. PMID: 25421805 Free PMC article.
-
Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV.World J Gastroenterol. 2005 Apr 14;11(14):2061-6. doi: 10.3748/wjg.v11.i14.2061. World J Gastroenterol. 2005. PMID: 15810069 Free PMC article.
-
Predictors of early and late hepatocellular carcinoma recurrence.World J Gastroenterol. 2023 Feb 28;29(8):1243-1260. doi: 10.3748/wjg.v29.i8.1243. World J Gastroenterol. 2023. PMID: 36925456 Free PMC article. Review.
-
What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection?Surg Today. 2022 Jun;52(6):871-880. doi: 10.1007/s00595-021-02352-z. Epub 2021 Aug 14. Surg Today. 2022. PMID: 34392420 Review.
Cited by
-
Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections.J Hepatocell Carcinoma. 2021 Mar 18;8:133-143. doi: 10.2147/JHC.S292010. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 33777855 Free PMC article.
-
Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.World J Gastroenterol. 2015 Jan 28;21(4):1207-15. doi: 10.3748/wjg.v21.i4.1207. World J Gastroenterol. 2015. PMID: 25632194 Free PMC article.
-
Interleukin-6 enhances cancer stemness and promotes metastasis of hepatocellular carcinoma via up-regulating osteopontin expression.Am J Cancer Res. 2016 Sep 1;6(9):1873-1889. eCollection 2016. Am J Cancer Res. 2016. PMID: 27725896 Free PMC article.
-
The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.PLoS One. 2015 Apr 1;10(4):e0118658. doi: 10.1371/journal.pone.0118658. eCollection 2015. PLoS One. 2015. PMID: 25830231 Free PMC article.
-
Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection.Sci Rep. 2021 Mar 15;11(1):6041. doi: 10.1038/s41598-021-85431-y. Sci Rep. 2021. PMID: 33723365 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical